US Patent 11857599 Compositions and methods for treating spinal muscular atrophy
Patent 11857599 was granted and assigned to Acceleron Pharma on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+420 characters)
US Patent 11857599 Compositions and methods for treating spinal muscular atrophy
Article
Patent abstract
In certain aspects, the disclosure provides compositions and methods for treating spinal muscular atrophy. For example, in some embodiments, the disclosure provides ALK4:ActRIIB antagonists that may be used to treat spinal muscular atrophy, particularly treating one or more complications of spinal muscular atrophy including, for example, increasing muscle mass muscle strength, and bone mineral density.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jia Li0
Rajasekhar Naga Venkata Sai Suragani0
Ravindra Kumar0
Date of Patent
January 2, 2024
0Patent Application Number
164990980
Date Filed
April 2, 2018
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11857599 Compositions and methods for treating spinal muscular atrophy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
